Page last updated: 2024-08-24

meglumine antimoniate and amphotericin b

meglumine antimoniate has been researched along with amphotericin b in 115 studies

Research

Studies (115)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (2.61)	18.7374
1990's	17 (14.78)	18.2507
2000's	37 (32.17)	29.6817
2010's	44 (38.26)	24.3611
2020's	14 (12.17)	2.80

Authors

Authors	Studies
Berman, JD; Chapman, WL; Hanson, WL; Ksionski, G; Waits, VB	1
Casillas, A; Costa, JR; de Dios Garcia, J; del Mar Sanz, M; Guijarro, C; Martinez, R; Rubio, R	1
Carvalho, EM; Costa, JL; Llanos-Cuentas, EA; Marsden, PD; Sampaio, RN; Veiga, JP	1
Barreto, AC; Cuba, CC; Guerra, M; Magalhâes, A; Marsden, PD; Rocha, RA; Sampaio, RN	1
Hanson, WL	1
Buffet, P; Caumes, E; Gentilini, M	1
Bryceson, A; Desjeux, P; Gradoni, L	1
Alcácer, F; Aznar, J; Colomina, J; Ferriols, F; Magraner, J; Orovitg, F; Rodilla, F	1
Gaeta, GB; Gradoni, L; Maisto, A; Pellizzer, G; Scalone, A	1
Betto, P; Davidson, RN; Giambenedetti, M; Gradoni, L; Orsini, S	1
Jurado, R; Kindelan, JM; Sanchez-Guijo, P; Torre-Cisneros, J; Villanueva, JL	1
Harhalakis, N; Lazanas, MC; Nikiforakis, E; Papandreou, S; Saroglou, G; Scandali, A; Tsekes, GA	1
Bourantas, C; Chaliasos, N; Kritikou, E; Lapatsanis, P	1
Derouin, F; Farinotti, R; Gangneux, JP; Garin, YJ; Sulahian, A	1
Buffet, PA; Derouin, F; Garin, YJ; Nassar, N; Sulahian, A	1
Camma, C; Cascio, A; Giordano, S; Gradoni, L; Gramiccia, M; Russo, R; Scalone, A; Scarlata, F; Titone, L	1
Dumon, H; Garnier, JM; Minodier, P; Perrimond, H; Piarroux, R; Unal, D	1
Dumon, H; Faraut-Gambarelli, F; Garnier, JM; Gire, C; Minodier, P; Piarroux, R	1
Chantraine, JM; Dresse, MF; Gillet, P; Hoyoux, C; Marguglio, A; Thiry, A	1
Alvar, J; Gómez-Rodrigo, J; Laguna, F; López-Vélez, R; Medrano, FJ; Pasquau, J; Picó, G; Pulido, F; Salas, A; Sanz, J; Torre-Cisneros, J; Torres, E	1
Holzmuller, P; Lemesre, JL; Sereno, D	1
González Lahoz, J; Laguna, F; Valencia, ME	1
Hepburn, NC	1
Alarcón, A; Alvar, J; Bernabeu-Wittel, M; Cordero, E; Prados, D; Regordán, C; Villanueva, JL	1
Berenguer, J; Cosín, J; López, JC; Miralles, P; Padilla, B	1
Guerin, JM; Leibinger, F; Masmoudi, R; Mofredj, A	1
Kafetzis, DA; Maltezou, HC	1
Antinori, S; Cascio, A; Colomba, C; Orobello, M; Paterson, D; Titone, L	1
Garnier, JM; Horelt, A; Minodier, P; Retornaz, K	1
Enk, CD; Gardlo, K; Hochberg, M; Ingber, A; Ruzicka, T	1
Alvar, J; Clotet, B; Jiménez-Mejías, ME; Laguna, F; López-Vélez, R; Prados, D; Ribera, E; Sirera, G; Sust, M; Torre-Cisneros, J; Videla, S	1
Darie, H; Debord, T; Gros, P; Imbert, P; Rapp, C; Roué, R; Simon, F	1
Gradoni, L; Gramiccia, M; Scalone, A	2
Bongrand, MC; Chochoi, N; Faraut, F; Gallais, H; Gensollen, S; Monges, P; Montana, M; Ravaux, I; Timon-David, P	1
Garnier, JM; Minodier, P; Retornaz, K; Robert, S	1
di Martino, L; Di Muccio, T; Gradoni, L; Gramiccia, M; Occorsio, P; Scalone, A	1
Colomba, C; Frasca Polara, V; Salsa, L; Scarlata, F; Titone, L	1
Amari, L; Belhaj, S; Ben Chaabene, T; Goubontini, A; Kilani, B	1
Delis, D; Kafetzis, DA; Liapi, G; Mavrikou, M; Stabouli, S; Velissariou, IM	1
Alvarez, N; Le Baut, G; Le Borgne, M; Le Pape, P; Lebouvier, N; Na, YM; Pagniez, F	1
Carvalho, SF; Costa, RT; De Almeida Silva, L; Nascimento, E; Prata, A; Rodrigues, V; Romero, HD	1
Kumar, PV; Mousavi, A; Rizvi, MM; Sadeghi, E; Sadeghipour, A; Soleimanpour, H; Tabatabaei, AH; Vasei, M	1
Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M	1
Aguado, JM; Costa, JR; López-Medrano, F; Rodriguez-Peralto, JL	1
Boucher, P; Hadighi, R; Khamesipour, A; Meamar, AR; Mohebali, M; Ouellette, M; Roy, G	1
Ammari, L; Belhadj, S; Ben Chaabene, T; Chaker, E; Kanoun, F; Kilani, B; Tiouiri, H; Toumi, A	1
Cavailler, P; Chappuis, F; Couffignal, S; Loutan, L; Mueller, Y; Nguimfack, A; Rwakimari, JB	1
Ayres, DC; Giorgio, S; Pinto, LA	1
Alborzi, A; Fakhar, M; Hatam, GR; Kadivar, MR; Motazedian, MH; Pouladfar, GR	1
Aragão, EB; Arruda, GA; Daher, EF; Evangelista, LF; Galeano, NM; Lima, RS; Mota, RM; Oliveira, RA; Silva Júnior, GB; Silva, SL	1
Díaz, E; Machuca, C; Padrón-Nieves, M; Ponte Sucre, A; Romero, A	1
Chang, KP; Dutta, S; Kolli, BK; Muñoz, DL; Muskus, C; Robledo, SM; Varela M, RE	1
Bacellar, O; Carvalho, EM; Guimarães, LH; Lago, EL; Machado, PR; Morgan, DJ; Schriefer, A	1
Buffet, PA; Bullani, R; de Vallière, S; Gillmore, JD; Greub, G; Joneberg, JE; Mary, C; Rotman, S; Tarr, PE	1
Daher, EF; Fonseca, PP; Gerhard, ES; Leitão, TM; Silva Júnior, GB	1
Dorta, ML; Miguel, DC; Pelli de Oliveira, MA; Pereira, LI; Ribeiro-Dias, F; Uliana, SR; Yokoyama-Yasunaka, JK; Zauli-Nascimento, RC	1
Arik Yilmaz, E; Tanir, G; Taylan Ozkan, A; Tuygun, N	1
Alvar, J; Balasegaram, M; Boelaert, M; Lynen, L; Meheus, F; van Griensven, J	1
Abreu, KL; Daher, EF; Franco, LF; Garcia, AV; Libório, AB; Mota, RM; Oliveira, MJ; Rocha, NA; Silva Júnior, GB	1
Brahn, E; Craft, N; Pegues, DA; Yao, Q	1
García Esteban, C; García-Bermejo, I; Guillén Martín, S; La Orden Izquierdo, E; Prieto Tato, LM; Ramos Amador, JT; Salcedo Lobato, E	1
Cedeño, DL; Jones, MA; Muñoz, DL; Robledo, SM; Taylor, VM; Vélez, ID	1
Alexandrino-de-Oliveira, P; da Cunha, RV; Da-Costa, Fd; Da-Cruz, AM; Dorval, ME; Paniago, AM; Pereira, GR; Santos-Oliveira, JR	1
Foto, E; Gradoni, L; Kuneshka, L; Petrela, R; Zavalani, F	1
Abderrahim, E; Bacha, MM; Bahloul, A; Ben Abdallah, T; Ben Maïz, H; Chaouech, D; Cherif, M; Khaled, S; Kheder, A; Ounissi, M; Rajhi, H; Trabelsi, S; Turki, S; Znaidi, N	1
Harms, G; Reiter-Owona, I; Richter, J; Scherbaum, H; Stich, A	1
Aït-Oudhia, K; Dedet, JP; Gazanion, E; Lachaud, L; Oury, B; Pratlong, F; Sereno, D	1
Chakravarty, J; Sundar, S	1
Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N	1
Antoniou, M; Christodoulou, V; Koutala, E; Mazeris, A; Messaritakis, I; Papadogiorgaki, S; Vlahou, A	1
Amorim, FM; Barbosa-Filho, JM; Caldas, JP; Leite, JA; Néris, PL; Oliveira, MR; Rodrigues, LC; Rodrigues, YK; Rodrigues-Mascarenhas, S	1
Mesquita, JT; Reimão, JQ; Tempone, AG	1
Cesetti, MV; de Morais, OO; Gomes, CM; Mendes, MS; Roselino, AM; Sampaio, RN	1
Ansari, S; Behnam, B; Mohebali, M; Sayyahfar, S	1
Kutlubay, Z; Polat, E	1
Aguirre-Urizar, JM; Araluce-Iturbe, I; Crovetto-De la Torre, MA; Crovetto-Martínez, R; Orte-Aldea, C; Whyte-Orozco, J	1
Awan, MM; Jamal, Q; Khan, NH; Shah, A; Sutherland, C; Wahid, S	1
Aksoy, M; Özbilgin, A; Sürücü, HA; Turan, E; Yeşilova, Y	1
Aoun, K; Harrat, Z; Laamrani El Idrissi, A; Marty, P	1
Aydın Teke, T; Bayhan, Gİ; Gayretli Aydın, ZG; Metin Timur, Ö; Mungan, M; Öz, N; Tanır, G; Yılmaz, N	1
Çakalağaoğlu, F; Demirdal, T; El, S; Kaptan, F; Örmen, B; Özkan Çayıröz, P; Sezak, N; Türker, N; Ural, S; Vardar, İ	1
Abdolahi Khabisi, S; Davami, MH; Ghatee, MA; Naraki, T; Sarkari, B	1
Aristides, SM; Fernandes, AC; Lonardoni, MV; Pedroso, RB; Silveira, TG; Venazzi, EA; Zanzarini, PD	1
Albuquerque, DR; Cruz, AF; de Lacerda, JC; Ferreira Aguiar, MC; Leite, CF; Resende, RG	1
Behdani, R; Mazloum Farsi Baf, M; Sasannejad, P; Zabolinejad, N	1
Barbosa, JF; Caligiorne, RB; de Figueiredo, SM; Lyon, S	1
Caljon, G; Croft, SL; Guerin, PJ; Hendrickx, S; Maes, L	1
Caridha, D; Grogl, M; Harris, M; Hickman, M; Hudson, TH; Lang, T; Lecoeur, H; Leed, S; Ngundam, F; O'Neil, M; Parriot, S; Read, L; Sciotti, R; Sena, J	1
Abbasi, I; Aguirre, C; Calvopina, M; Castillo, A; Cevallos, W; Warburg, A	1
Marcoval, J; Penín, RM	1
Alves, FP; Amaral, TA; Costa, CHN; Costa, DL; de Almeida, RP; de Carvalho, AL; de Carvalho, SFG; de Melo, EV; Leite, RD; Lima, SS; Rabello, A; Rode, J; Romero, GAS; Sousa, AQ	1
Singh, A; Sundar, S	1
Clavijo, A; Gavilan, C; González de Dios, J; Moral, L; Ramos, JM; Salvador, T	1
Carbone, DCB; Carvalho, CME; Cônsolo, FZ; Muller, KTC; Reis, VQD; Sanches, SC; Silva, MC; Zanoni, LZG	1
Aguayo-Carreras, P; Cuenca-Barrales, C; Perez-López, I; Ruiz-Villaverde, R; Tercedor-Sanchez, J	1
Bamorovat, M; Farajzadeh, S; Kakooei, S; Keyhani, A; Khamesipour, A; Khazaeli, P; Khosravi, A; Mostafavi, M; Parizi, MH; Pourseyedi, E; Sharifi, H; Sharifi, I	1
de Carvalho, IPSF; de Oliveira, MRF; Peixoto, HM; Romero, GAS	1
Marques, MEA; Marques, SA; Merlotto, MR; Ramos, PM	1
Gholami, E; Habibzadeh, S; Heidari-Kharaji, M; Khadir, F; Oryan, A; Rafati, S; Taheri, T; Zahedifard, F	1
Camara, L; Queirós, J; Ribeiro, R; Teófilo, E	1
Cunha, MAD; Luz, KG; Shaw, JJ; Sousa, ASV; Vechi, HT	1
Botella-Estrada, R; Castro-Hernández, I; Chouman-Arcas, R; Garrido-Jareño, M; Gómez-Ruiz, MD; Llavador-Ros, M; López-Hontangas, JL; Molina-Moreno, JM; Pemán-García, J; Sahuquillo-Torralba, A; Salavert-Lleti, M	1
Alcoba, G; Blaizot, R; Cissé, H; Couppie, P; Demar, M; Ginouves, M; Prevot, G; Senchyna, A; Simon, S	1
Araújo, AJ; Carvalho, FAA; Costa, LH; da Silva, MV; Marinho Filho, JDB; Noleto Dias, C; Nunes, TAL; Oliveira, MR; Rodrigues, KADF; Rodrigues, RRL; Sousa, JMS	1
Çavuş, İ; Harman, M; Kaya, T; Özbilgin, A; Yıldırım, A	1
da Silva, JHM; de Barros, NB; de Figueiredo Nicolete, LD; Dos Santos Ferreira, A; Macedo, SRA; Nicolete, R; Valentim-Silva, JR	1
Bartoloni, A; Basile, G; Bresci, S; Cristofaro, G; Di Muccio, T; Gaiera, G; Gallo, O; Gradoni, L; Gramiccia, M; Locatello, LG; Maggiore, G; Novelli, A; Piccica, M; Vellere, I; Zammarchi, L	1
Alves, MLR; Bandeira, CC; de Faria, BG; Giunchetti, RC; Peruhype-Magalhães, V; Ribeiro, JM; Souza-Fagundes, EM; Teixeira-Carvalho, A; Uzonna, JE; Vieira, FO	1
Bartoloni, A; Bartolozzi, D; Corsi, P; Di Muccio, T; Gramiccia, M; Spinicci, M; Trotta, M; Zammarchi, L	1
Campos, MP; Figueiredo, FB; Gonçalves, AS; Gonçalves, G; Medeiros, LCS	1
Chiheb, S; Dahbi, HS; Darif, D; El Idrissi Saik, I; Fatoiki, FZE; Hali, F; Hammi, I; Kihel, A; Riyad, M; Soussi Abdellaoui, M; Tazi Saoud, Z	1
Araújo, MS; Bartholomeu, DC; Borges, VM; Cardoso, CDA; Laurenti, MD; Monte-Neto, RLD; Moreira, POL; Nogueira, PM; Rêgo, FD; Reis, AB; Soares, RP	1
Afshari, F; Eskandari, S; Firooz, A; Jaafari, M; Javadi, A; Khamesipour, A; Mohammadi, A; Mortazavi, H; Tasbihi, M	1
Barbosa, JS; Barroso, DH; da Motta, JOC; Freire, GSM; Gomes, CM; Gonçalves, RT; Sampaio, RNR	1

Reviews

17 review(s) available for meglumine antimoniate and amphotericin b

Article	Year
Chemotherapy and the immune response in protozoal infections. The Journal of protozoology, 1981, Volume: 28, Issue:1 Topics: Adjuvants, Immunologic; Amphotericin B; Animals; Antibody Formation; Antimalarials; Antimony; Antiprotozoal Agents; Humans; Immune Tolerance; Immunity, Cellular; Meglumine; Meglumine Antimoniate; Metronidazole; Nifurtimox; Organometallic Compounds; Protozoan Infections	1981
[Treatment of localized cutaneous leishmaniasis]. Annales de dermatologie et de venereologie, 1994, Volume: 121, Issue:6-7 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Itraconazole; Ketoconazole; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine	1994
Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17, Issue:4 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Drug Carriers; Drug Resistance; Follow-Up Studies; HIV-1; Humans; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1993
[Treatment of infantile visceral leishmaniasis]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1999, Volume: 6, Issue:1 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Resistance; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Time Factors; Treatment Outcome	1999
Cutaneous leishmaniasis. Clinical and experimental dermatology, 2000, Volume: 25, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Cutaneous; Life Cycle Stages; Macrophages; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence; Skin	2000
Visceral leishmaniasis in paediatrics. Current opinion in infectious diseases, 2002, Volume: 15, Issue:3 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Child; Disease Vectors; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prevalence	2002
Liposomal amphotericin B in the treatment of visceral leishmaniasis in immunocompetent patients. Fundamental & clinical pharmacology, 2003, Volume: 17, Issue:2 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Drug Administration Schedule; Drug Combinations; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Treatment Failure	2003
[Cutaneous leishmaniasis]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:6 Topics: Amphotericin B; Anti-Bacterial Agents; Antimony Sodium Gluconate; Antiprotozoal Agents; Controlled Clinical Trials as Topic; Diagnosis, Differential; Double-Blind Method; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Paromomycin; Photochemotherapy; Time Factors	2003
[Liposomal amphotericin B in secondary prophylaxis of visceral leishmaniasis in HIV-infected patients: report of five clinical cases]. Pathologie-biologie, 2004, Volume: 52, Issue:2 Topics: Adult; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Drug Evaluation; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Recurrence; Retrospective Studies; Substance Abuse, Intravenous; Treatment Outcome	2004
[Visceral leishmaniasis: new drugs]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10 Suppl 5 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2003
[Change in human visceral leishmaniasis treatment in Italy: retrospective study of 630 patients]. Parassitologia, 2004, Volume: 46, Issue:1-2 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Child; Clinical Trials as Topic; Drug Utilization; Humans; Immunocompetence; Italy; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome	2004
[Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre]. Parassitologia, 2004, Volume: 46, Issue:1-2 Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cluster Analysis; Disease Outbreaks; Female; Humans; Infant; Italy; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Morbidity; Organometallic Compounds; Retrospective Studies	2004
[Treatment of visceral leishmaniasis in children]. Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:1 Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2007
Combination therapy for visceral leishmaniasis. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:3 Topics: Amphotericin B; Antiprotozoal Agents; Asia; Brazil; Cost-Benefit Analysis; Drug Therapy, Combination; Europe; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Safety; South Africa	2010
Leishmaniasis: an update of current pharmacotherapy. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:1 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Species Specificity; Treatment Outcome	2013
Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology, 2018, Volume: 145, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Parasitic Sensitivity Tests; Phosphorylcholine; Psychodidae; Recurrence	2018
Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology, 2018, Volume: 145, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Psychodidae; Sheep; South America; Treatment Outcome	2018

Trials

6 trial(s) available for meglumine antimoniate and amphotericin b

Article	Year
Treatment of Mediterranean visceral leishmaniasis. Bulletin of the World Health Organization, 1995, Volume: 73, Issue:2 Topics: Adolescent; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Europe; Humans; Infant; Leishmaniasis, Visceral; Liposomes; Mediterranean Islands; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1995
Treatment of visceral leishmaniasis in HIV-infected patients: a randomized trial comparing meglumine antimoniate with amphotericin B. Spanish HIV-Leishmania Study Group. AIDS (London, England), 1999, Jun-18, Volume: 13, Issue:9 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prospective Studies; Spain; Treatment Outcome	1999
Prospective evaluation and follow-up of European patients with visceral leishmaniasis and HIV-1 coinfection in the era of highly active antiretroviral therapy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2000, Volume: 19, Issue:10 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Europe; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prospective Studies	2000
Amphotericin B lipid complex versus meglumine antimoniate in the treatment of visceral leishmaniasis in patients infected with HIV: a randomized pilot study. The Journal of antimicrobial chemotherapy, 2003, Volume: 52, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Double-Blind Method; Drug Combinations; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Pilot Projects; Treatment Outcome	2003
Efficacy and safety of available treatments for visceral leishmaniasis in Brazil: A multicenter, randomized, open label trial. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:6 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome; Young Adult	2017
Pilot study of safety and efficacy of topical liposomal amphotericin B for cutaneous leishmaniasis caused by Leishmania major in Islamic Republic of Iran. Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit, 2022, Sep-29, Volume: 28, Issue:9 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; Humans; Iran; Leishmania major; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pilot Projects; Treatment Outcome	2022

Other Studies

92 other study(ies) available for meglumine antimoniate and amphotericin b

Article	Year
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:9 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cholesterol Esters; Cricetinae; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1992
Visceral leishmaniasis in HIV-infected patients. AIDS (London, England), 1991, Volume: 5, Issue:10 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Spain; Treatment Outcome	1991
High continuous antimony therapy in two patients with unresponsive mucosal leishmaniasis. The American journal of tropical medicine and hygiene, 1985, Volume: 34, Issue:4 Topics: Adult; Amphotericin B; Antimony; Antimony Sodium Gluconate; Child; Gluconates; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds	1985
Apparent Glucantime failure in five patients with mucocutaneous leishmaniasis. The Journal of tropical medicine and hygiene, 1980, Volume: 83, Issue:4 Topics: Amphotericin B; Antigens; Antimony; Brazil; Female; Fluorescent Antibody Technique; Humans; Leishmania; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Sorbitol	1980
Amphotericin B for visceral leishmaniasis resistant to pentavalent antimonial drugs in AIDS. The Annals of pharmacotherapy, 1994, Volume: 28, Issue:11 Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pentamidine; Substance Abuse, Intravenous	1994
Mediterranean visceral leishmaniasis in pregnancy. Scandinavian journal of infectious diseases, 1994, Volume: 26, Issue:5 Topics: Adult; Amphotericin B; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Female; Humans; Infant, Newborn; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pregnancy; Pregnancy Complications, Parasitic; Serologic Tests	1994
Activity of liposomal amphotericin B (AmBisome) against Leishmania infantum and tissue distribution in mice. Journal of drug targeting, 1993, Volume: 1, Issue:4 Topics: Amphotericin B; Animals; Cricetinae; HIV Infections; Humans; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Liver; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Spleen; Tissue Distribution	1993
Liposomal amphotericin B for leishmaniasis treatment of AIDS patients unresponsive to antimonium compounds. AIDS (London, England), 1993, Volume: 7, Issue:7 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Dosage Forms; Female; Humans; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds	1993
A 7-month-old girl with fever and bleeding. Lancet (London, England), 1996, Apr-20, Volume: 347, Issue:9008 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Dicloxacillin; Female; Humans; Infant; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Skin Diseases	1996
Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome. Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Carriers; Female; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds	1996
Therapeutic effect of reference antileishmanial agents in murine visceral leishmaniasis due to Leishmania infantum. Annals of tropical medicine and parasitology, 1996, Volume: 90, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Female; Leishmania infantum; Leishmaniasis, Visceral; Liver Diseases, Parasitic; Lung Diseases, Parasitic; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitology; Paromomycin; Splenic Diseases	1996
Epidemiologic surveillance of visceral leishmaniasis in Sicily, Italy. The American journal of tropical medicine and hygiene, 1997, Volume: 57, Issue:1 Topics: Adolescent; Adult; Age Distribution; Aged; Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; HIV Infections; Humans; Infant; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Sex Distribution; Sicily	1997
Pediatric visceral leishmaniasis in southern France. The Pediatric infectious disease journal, 1998, Volume: 17, Issue:8 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; France; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Quaternary Ammonium Compounds; Retrospective Studies; Treatment Failure; Treatment Outcome	1998
[Chronic visceral leishmaniasis during chemotherapy for metastatic osteosarcoma]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 1998, Volume: 5, Issue:3 Topics: Amphotericin B; Antifungal Agents; Antimony; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Child; Chronic Disease; Humans; Interferon-gamma; Leishmaniasis, Visceral; Liposomes; Lung Neoplasms; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Osteosarcoma; Recurrence; Spinal Neoplasms	1998
Efficacy of second line drugs on antimonyl-resistant amastigotes of Leishmania infantum. Acta tropica, 2000, Jan-05, Volume: 74, Issue:1 Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Cell Line; Drug Resistance; Humans; Leishmania infantum; Meglumine; Meglumine Antimoniate; Mutation; Organometallic Compounds; Pentamidine	2000
[Nephrotic syndrome and acute pancreatitis related to glucantime administration]. Anales de medicina interna (Madrid, Spain : 1984), 2000, Volume: 17, Issue:1 Topics: Acute Disease; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antimony; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Nephrotic Syndrome; Organometallic Compounds; Pancreatitis	2000
Discontinuation of secondary anti-leishmania prophylaxis in HIV-infected patients who have responded to highly active antiretroviral therapy. AIDS (London, England), 2000, Dec-22, Volume: 14, Issue:18 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Chemoprevention; Female; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Treatment Outcome	2000
Visceral leishmaniasis with pericarditis in an HIV-infected patient. Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:2 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Candida albicans; Candidiasis; HIV Infections; Humans; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Pericarditis	2002
Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2002, Volume: 21, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Humans; Infant; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Nutrition Disorders; Organometallic Compounds; Recurrence; Retrospective Studies; Sicily; Treatment Outcome	2002
[Liposomal amphotericin B treatment of cutaneous leishmaniasis contracted in Djibouti and resistant to meglumine antimoniate]. Bulletin de la Societe de pathologie exotique (1990), 2003, Volume: 96, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Djibouti; Drug Resistance; France; Humans; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Military Personnel; Organometallic Compounds	2003
Visceral leishmaniasis treatment, Italy. Emerging infectious diseases, 2003, Volume: 9, Issue:12 Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Drug Combinations; Drug Therapy; Humans; Italy; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies	2003
[Mediterranean visceral leishmaniasis in immunocompetent children. Report of two cases relapsed after specific therapy]. Le infezioni in medicina, 2004, Volume: 12, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Female; Humans; Immunocompetence; Infant; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitemia; Recurrence	2004
[Relapse of visceral leishmaniasis in HIV infection. Benefit of amphotericin B]. La Tunisie medicale, 2004, Volume: 82, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Follow-Up Studies; HIV Seropositivity; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Time Factors	2004
Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds? International journal of antimicrobial agents, 2005, Volume: 25, Issue:1 Topics: Adolescent; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Child, Preschool; Female; Greece; Humans; Infant; Infant, Newborn; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2005
Synthesis and antileishmanial activity of 3-imidazolylalkylindoles. Part I. Journal of enzyme inhibition and medicinal chemistry, 2004, Volume: 19, Issue:6 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Proliferation; Drug Evaluation, Preclinical; Fibroblasts; Humans; In Vitro Techniques; Indoles; Ketoconazole; Leishmania mexicana; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Molecular Structure; Organometallic Compounds; Parasitic Sensitivity Tests; Stereoisomerism; Structure-Activity Relationship	2004
Immunologic tests in patients after clinical cure of visceral leishmaniasis. The American journal of tropical medicine and hygiene, 2006, Volume: 75, Issue:4 Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Chromatography; Dogs; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Fluorescent Antibody Technique, Indirect; Humans; Immunologic Tests; Infant; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Skin Tests; Time Factors	2006
Visceral leishmaniasis: bone marrow biopsy findings. Journal of pediatric hematology/oncology, 2007, Volume: 29, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Biopsy; Bone Marrow; Bone Marrow Examination; Child; Child, Preschool; Female; Fibrosis; Granuloma; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Necrosis; Organometallic Compounds; Prognosis; Retrospective Studies	2007
An HIV-positive man with tattoo induration. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Jul-15, Volume: 45, Issue:2 Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antiprotozoal Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; HIV Seropositivity; Humans; Immunohistochemistry; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Risk Assessment; Tattooing	2007
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitology research, 2007, Volume: 101, Issue:5 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine	2007
[Demographic, clinical and therapeutic features of adult visceral leishmaniasis at the Rabta hospital in Tunis (tunisia) from 1983 to 2002]. Bulletin de la Societe de pathologie exotique (1990), 2007, Volume: 100, Issue:4 Topics: Adult; Amphotericin B; Anemia; Animals; Antimony; Antiprotozoal Agents; Fever; HIV Infections; Humans; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Splenomegaly; Treatment Outcome; Tunisia	2007
Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda. Annals of tropical medicine and parasitology, 2008, Volume: 102, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Kenya; Leishmania donovani; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Statistics as Topic; Treatment Outcome; Uganda	2008
Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions. The Journal of parasitology, 2008, Volume: 94, Issue:6 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Hypoxia; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania mexicana; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Oxygen; Phosphorylcholine	2008
Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. The American journal of tropical medicine and hygiene, 2008, Volume: 79, Issue:3 Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Interferon-gamma; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2008
Clinical presentation and renal evaluation of human visceral leishmaniasis (kala-azar): a retrospective study of 57 patients in Brazil. The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases, 2008, Volume: 12, Issue:4 Topics: Acute Kidney Injury; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Ureohydrolases	2008
Glibenclamide modulates glucantime activity and disposition in Leishmania major. Experimental parasitology, 2009, Volume: 121, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; ATP-Binding Cassette Transporters; Cells, Cultured; Drug Synergism; Glyburide; Leishmania major; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Electron; Organometallic Compounds	2009
Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug. Experimental parasitology, 2009, Volume: 122, Issue:2 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Flow Cytometry; Gene Expression; Green Fluorescent Proteins; Humans; Leishmania guyanensis; Luminescent Agents; Macrophages; Meglumine; Meglumine Antimoniate; Microscopy, Fluorescence; Microscopy, Phase-Contrast; Organometallic Compounds; Transfection; U937 Cells	2009
Atypical manifestations of tegumentary leishmaniasis in a transmission area of Leishmania braziliensis in the state of Bahia, Brazil. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2009, Volume: 103, Issue:7 Topics: Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Brazil; Facial Dermatoses; Female; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pregnancy; Pregnancy Complications, Parasitic; Prognosis; Risk Assessment; Risk Factors; Treatment Outcome; Young Adult	2009
AA-amyloidosis caused by visceral leishmaniasis in a human immunodeficiency virus-infected patient. The American journal of tropical medicine and hygiene, 2009, Volume: 81, Issue:2 Topics: Amphotericin B; Amyloidosis; Anti-HIV Agents; Antiprotozoal Agents; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Young Adult	2009
Clinical and epidemiological features of visceral leishmaniasis and HIV co-infection in fifteen patients from Brazil. The Journal of parasitology, 2009, Volume: 95, Issue:3 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Asthenia; Bone Marrow; Brazil; CD4 Lymphocyte Count; Cough; Diarrhea; Female; Fever; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Splenomegaly; Time Factors; Weight Loss	2009
In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B. Tropical medicine & international health : TM & IH, 2010, Volume: 15, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmania mexicana; Leishmaniasis, Cutaneous; Macrophages; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Parasitic Sensitivity Tests	2010
Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience. Turkiye parazitolojii dergisi, 2009, Volume: 33, Issue:4 Topics: Adolescent; Age Distribution; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Recurrence; Retrospective Studies; Treatment Outcome; Turkey	2009
Risk factors for acute kidney injury in visceral leishmaniasis (Kala-Azar). The American journal of tropical medicine and hygiene, 2010, Volume: 82, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Female; Humans; Kidney Diseases; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Young Adult	2010
Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2010, Volume: 16, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Brazil; California; Diagnosis, Differential; Female; Granulomatosis with Polyangiitis; Humans; Infusions, Intravenous; Leishmaniasis, Mucocutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Referral and Consultation	2010
[Visceral childhood leishmaniasis: diagnosis and treatment]. Anales de pediatria (Barcelona, Spain : 2003), 2010, Volume: 72, Issue:5 Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Child; Child, Preschool; Female; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies	2010
Leishmania tarentolae: utility as an in vitro model for screening of antileishmanial agents. Experimental parasitology, 2010, Volume: 126, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cells, Cultured; Cricetinae; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmania braziliensis; Leishmania guyanensis; Lizards; Macrophages; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mesocricetus; Organometallic Compounds; U937 Cells	2010
HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil. Memorias do Instituto Oswaldo Cruz, 2010, Volume: 105, Issue:5 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiprotozoal Agents; Brazil; CD4 Lymphocyte Count; Endemic Diseases; Female; Humans; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Risk Factors; Viral Load; Young Adult	2010
Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009). PLoS neglected tropical diseases, 2010, Sep-07, Volume: 4, Issue:9 Topics: Adolescent; Albania; Amphotericin B; Antiprotozoal Agents; Bone Marrow; Child; Child, Preschool; Female; Hospitalization; Humans; Incidence; Infant; Infant, Newborn; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Microscopy; Organometallic Compounds; Parasitology; Retrospective Studies; Serologic Tests	2010
[Association of post-transplant lymphoproliferative disease and visceral leishmaniasis after kidney transplantation]. Nephrologie & therapeutique, 2011, Volume: 7, Issue:6 Topics: Adult; Amphotericin B; Antibodies, Monoclonal, Murine-Derived; Antiprotozoal Agents; Antiviral Agents; Epstein-Barr Virus Infections; Ganciclovir; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leishmaniasis, Visceral; Lymphoproliferative Disorders; Male; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Postoperative Complications; Remission Induction; Rituximab; Sirolimus	2011
Treatment of imported New World cutaneous leishmaniasis in Germany. International journal of dermatology, 2011, Volume: 50, Issue:11 Topics: Adolescent; Adult; Aged; Amphotericin B; Animals; Antiprotozoal Agents; Female; Germany; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Travel; Young Adult	2011
In vitro susceptibility to antimonials and amphotericin B of Leishmania infantum strains isolated from dogs in a region lacking drug selection pressure. Veterinary parasitology, 2012, Jul-06, Volume: 187, Issue:3-4 Topics: Algeria; Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Dog Diseases; Dogs; Dose-Response Relationship, Drug; Drug Resistance; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds	2012
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Experimental parasitology, 2013, Volume: 135, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine	2013
Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression. PloS one, 2013, Volume: 8, Issue:6 Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Leishmania donovani; Meglumine; Meglumine Antimoniate; Membrane Proteins; Organometallic Compounds; Phosphorylcholine; Protozoan Proteins; Rhodamine 123	2013
Neolignan Licarin A presents effect against Leishmania (Leishmania) major associated with immunomodulation in vitro. Experimental parasitology, 2013, Volume: 135, Issue:2 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Apoptosis; Cytokines; DNA Fragmentation; Female; Immunologic Factors; Inhibitory Concentration 50; Leishmania major; Leishmaniasis, Cutaneous; Lignans; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Nitric Oxide; Organometallic Compounds	2013
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes. Acta tropica, 2014, Volume: 130 Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles	2014
The influence of treatment on the development of leishmaniasis recidiva cutis: a 17-year case-control study in Midwestern Brazil. Journal of the European Academy of Dermatology and Venereology : JEADV, 2015, Volume: 29, Issue:1 Topics: Adolescent; Adult; Amphotericin B; Brazil; Case-Control Studies; Female; Humans; Incidence; Leishmaniasis, Cutaneous; Longitudinal Studies; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pentamidine; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Trypanocidal Agents; Young Adult	2015
Visceral leishmaniasis without fever in an 11-month-old infant: a rare clinical feature of Kala-azar. The Korean journal of parasitology, 2014, Volume: 52, Issue:2 Topics: Amphotericin B; Anemia; Antiprotozoal Agents; Deoxycholic Acid; Diagnosis, Differential; Drug Combinations; Endemic Diseases; Fever; Humans; Infant; Iran; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Splenomegaly	2014
[Four cutaneous leishmaniosis case resistant to meglumine antimoniate treatment]. Turkiye parazitolojii dergisi, 2014, Volume: 38, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Diptera; DNA, Intergenic; DNA, Protozoan; Drug Resistance; Humans; Larva; Leishmania; Leishmania major; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Treatment Outcome	2014
Mucocutaneous leishmaniasis must be included in the differential diagnosis of midline destructive disease: two case reports. Oral surgery, oral medicine, oral pathology and oral radiology, 2015, Volume: 119, Issue:1 Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Combined Modality Therapy; Diagnosis, Differential; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Mouth Diseases; Nose Diseases; Organometallic Compounds	2015
In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs. Experimental parasitology, 2015, Volume: 154 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line, Tumor; Child; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Meglumine Antimoniate; Naphthoquinones; Organometallic Compounds; Pakistan; Parasitic Sensitivity Tests	2015
[Successful treatment of cutaneous leishmaniasis with amphotericin B; a case of unresponsive to pentavalent antimony therapy]. Turkiye parazitolojii dergisi, 2015, Volume: 39, Issue:1 Topics: Administration, Intravenous; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Injections, Intralesional; Injections, Intramuscular; Insect Bites and Stings; Insect Vectors; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus	2015
[Meeting "Visceral leishmaniasis in Maghreb", 2-4 April 2015 in Tunis. Recommendations]. Bulletin de la Societe de pathologie exotique (1990), 2015, Volume: 108, Issue:3 Topics: Africa, Northern; Amphotericin B; Animals; Antiprotozoal Agents; Developing Countries; Disease Management; Disease Reservoirs; Dog Diseases; Dogs; Drug Substitution; Early Diagnosis; Humans; Immunologic Tests; Insect Control; Insect Vectors; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phlebotomus; Zoonoses	2015
[Three Pediatric Cases of Leishmaniasis with Different Clinical Forms and Treatment Regimens]. Turkiye parazitolojii dergisi, 2015, Volume: 39, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Child, Preschool; Humans; Iran; Iraq; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Turkey	2015
[Evaluation of clinical and laboratory findings of adult visceral leishmaniasis cases]. Mikrobiyoloji bulteni, 2015, Volume: 49, Issue:4 Topics: Administration, Intravenous; Adolescent; Adult; Aged; Amphotericin B; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Bone Marrow; Female; Humans; Injections, Intramuscular; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult	2015
Visceral Leishmaniasis in Southwestern Iran: A Retrospective Clinico-Hematological Analysis of 380 Consecutive Hospitalized Cases (1999-2014). PloS one, 2016, Volume: 11, Issue:3 Topics: Adolescent; Adult; Aged; Amphotericin B; Bone Marrow Cells; C-Reactive Protein; Child; Child, Preschool; Female; Hospitalization; Humans; Infant; Iran; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Pancytopenia; Retrospective Studies; Thrombocytopenia; Young Adult	2016
AMERICAN CUTANEOUS LEISHMANIASIS WITH UNUSUAL CLINICAL PRESENTATION AND RESPONSE TO TREATMENT. Revista do Instituto de Medicina Tropical de Sao Paulo, 2016, Volume: 58 Topics: Amphotericin B; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Treatment Outcome	2016
Mucosal leishmaniasis in Brazilian patients: two case reports with similar clinical presentation and different approaches. Oral surgery, oral medicine, oral pathology and oral radiology, 2016, Volume: 122, Issue:6 Topics: Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Brazil; Fatal Outcome; Humans; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Mouth Mucosa; Organometallic Compounds; Polymerase Chain Reaction; Skin Tests	2016
Leishmaniasis with Femoral Bone Involvement. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2016, Volume: 26, Issue:6 Suppl Topics: Amphotericin B; Antibodies, Protozoan; Antiprotozoal Agents; Bone Marrow; Femur; Humans; Knee; Leishmania; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Tomography, X-Ray Computed; Treatment Outcome	2016
An 8-Year Retrospective Study of Human Visceral Leishmaniasis. Current clinical pharmacology, 2016, Volume: 11, Issue:4 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Child; Child, Preschool; Coinfection; Female; HIV Infections; Humans; Infant; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Recurrence; Retrospective Studies; Sex Distribution; Young Adult	2016
Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Cell Survival; Drug Evaluation, Preclinical; Female; Firefly Luciferin; Fluconazole; Genes, Reporter; High-Throughput Screening Assays; Leishmania major; Leishmaniasis, Cutaneous; Luciferases; Luminescent Measurements; Macrophages; Meglumine; Meglumine Antimoniate; Mesocricetus; Mice; Mice, Inbred BALB C; Ofloxacin; Optical Imaging; Organisms, Genetically Modified; Organometallic Compounds; Triazoles	2017
Coinfection of The American journal of tropical medicine and hygiene, 2017, Volume: 96, Issue:5 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Cytochromes b; Fatal Outcome; HIV; HIV Infections; Humans; Leishmania guyanensis; Leishmaniasis, Diffuse Cutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Protozoan Proteins; Sequence Analysis, DNA; Shock, Septic; Skin; Treatment Failure	2017
Evolution of cutaneous leishmaniasis in the last 30 years in a tertiary hospital of the European Mediterranean coast. International journal of dermatology, 2017, Volume: 56, Issue:7 Topics: Acquired Immunodeficiency Syndrome; Adult; Age Factors; Aged; Amphotericin B; Antiprotozoal Agents; Female; Humans; Immunocompromised Host; Kidney Transplantation; Leishmaniasis, Cutaneous; Male; Mediterranean Region; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Retrospective Studies; Severity of Illness Index; Tertiary Care Centers; Tumor Necrosis Factor-alpha	2017
Epidemiological and clinical features of visceral leishmaniasis in children in Alicante Province, Spain. Paediatrics and international child health, 2018, Volume: 38, Issue:3 Topics: Adolescent; Amphotericin B; Antibodies, Protozoan; Antiprotozoal Agents; Blood; Bone Marrow; Child; Child, Preschool; Female; Humans; Infant; Infant, Newborn; Leishmania; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Retrospective Studies; Spain	2018
Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area. Revista do Instituto de Medicina Tropical de Sao Paulo, 2018, Volume: 60 Topics: Amphotericin B; Antiprotozoal Agents; Biomarkers; Case-Control Studies; Child; Child, Preschool; Dietary Supplements; Endemic Diseases; Female; Humans; Infant; Leishmaniasis, Visceral; Liver; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Spleen; Zinc	2018
Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent. International journal of dermatology, 2019, Volume: 58, Issue:7 Topics: Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Foreskin; Humans; Infusions, Intravenous; Injections, Intralesional; Leishmania; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Treatment Outcome	2019
Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 116 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Apoptosis; Cell Line; Drug Therapy, Combination; Gene Expression Regulation; Inhibitory Concentration 50; Leishmania major; Liposomes; Macrophages; Meglumine Antimoniate; Mice, Inbred BALB C; Parasites; Spleen	2019
Treatment for human visceral leishmaniasis: a cost-effectiveness analysis for Brazil. Tropical medicine & international health : TM & IH, 2019, Volume: 24, Issue:9 Topics: Amphotericin B; Antiprotozoal Agents; Brazil; Cost-Benefit Analysis; Drug Therapy, Combination; Health Resources; Health Services; Humans; Leishmaniasis, Visceral; Meglumine Antimoniate; Models, Econometric	2019
American tegumentary leishmaniasis: severe side effects of pentavalent antimonial in a patient with chronic renal failure. Anais brasileiros de dermatologia, 2019, 07-29, Volume: 94, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Brazil; Drug-Related Side Effects and Adverse Reactions; Humans; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Renal Dialysis; Renal Insufficiency, Chronic	2019
Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection. Veterinary parasitology, 2019, Volume: 276 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line, Tumor; Cytokines; Female; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Lymph Nodes; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Microscopy, Electron, Scanning; Microscopy, Electron, Transmission; Parasite Load; Random Allocation; Sirolimus; TOR Serine-Threonine Kinases	2019
Meglumine antimoniate combination treatment for relapsing Kala-azar after treatment and secondary prophylaxis failure with liposomal amphotericin B in two HIV-coinfected patients. BMJ case reports, 2019, Dec-16, Volume: 12, Issue:12 Topics: Adult; Amphotericin B; Atovaquone; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Meglumine Antimoniate; Middle Aged; Recurrence; Secondary Prevention; Treatment Outcome	2019
Case Report: Combination Therapy with Liposomal Amphotericin B, N-Methyl Meglumine Antimoniate, and Pentamidine Isethionate for Disseminated Visceral Leishmaniasis in a Splenectomized Adult Patient. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; Drug Therapy, Combination; Humans; Immunocompromised Host; Intestinal Mucosa; Leishmaniasis, Visceral; Lymph Nodes; Male; Meglumine Antimoniate; Middle Aged; Pentamidine; Splenectomy	2020
Cutaneous and mucocutaneous leishmaniasis: experience of a Mediterranean hospital. Parasites & vectors, 2020, Jan-13, Volume: 13, Issue:1 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Female; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Middle Aged; Retrospective Studies; Risk Factors; Spain; Young Adult	2020
American cutaneous leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate. The British journal of dermatology, 2020, Volume: 183, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; French Guiana; Humans; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Retrospective Studies; United States	2020
Methyl gallate: Selective antileishmanial activity correlates with host-cell directed effects. Chemico-biological interactions, 2020, Apr-01, Volume: 320 Topics: Amphotericin B; Antiprotozoal Agents; Gallic Acid; Gene Expression Regulation; Leishmania; Macrophages; Meglumine Antimoniate; Molecular Structure; Reactive Oxygen Species	2020
Comparison of Turkiye parazitolojii dergisi, 2020, Mar-20, Volume: 44, Issue:1 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Genotyping Techniques; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Real-Time Polymerase Chain Reaction; Turkey	2020
Antileishmanial drugs activate inflammatory signaling pathways via toll-like receptors (docking approach) from Leishmania amazonensis-infected macrophages. International immunopharmacology, 2020, Volume: 85 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Inflammation; Leishmania; Leishmaniasis; Macrophages; Meglumine Antimoniate; Mice; Mitogen-Activated Protein Kinases; Molecular Docking Simulation; Pentamidine; Signal Transduction; Toll-Like Receptors; Transcription Factor RelA	2020
Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2020, Volume: 97 Topics: Administration, Intravenous; Aged; Amphotericin B; Antiprotozoal Agents; Argentina; Azoles; Drug Therapy, Combination; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine Antimoniate; Pentamidine; Recurrence	2020
An ex vivo multiparametric flow cytometry assay using human whole blood to simultaneously measure cytotoxicity and leishmanicidal activities. Experimental parasitology, 2020, Volume: 216 Topics: Adult; Amphotericin B; Animal Testing Alternatives; Animals; Antiprotozoal Agents; Drug Discovery; Drug Evaluation, Preclinical; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Leishmania; Leishmania braziliensis; Leishmaniasis; Leukocytes; Meglumine Antimoniate; Microscopy, Confocal; Middle Aged; Monocytes; Neglected Diseases; Time Factors; Young Adult	2020
Effective meglumine antimoniate intralesional therapy for Chiclero's ulcer refractory to systemic liposomal amphotericin B. Journal of travel medicine, 2021, 08-27, Volume: 28, Issue:6 Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Ulcer	2021
Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol. Parasites & vectors, 2021, Dec-09, Volume: 14, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine	2021
[Generalized old world leishmaniasis: first Moroccan case in an immunocompetent adult?] Medecine tropicale et sante internationale, 2021, 12-31, Volume: 1, Issue:4 Topics: Adult; Amphotericin B; Humans; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Meglumine Antimoniate	2021
Leishmania amazonensis from distinct clinical forms/hosts has polymorphisms in Lipophosphoglycans, displays variations in immunomodulatory properties and, susceptibility to antileishmanial drugs. Cell biology international, 2022, Volume: 46, Issue:11 Topics: Amphotericin B; Animals; Dogs; Glycosphingolipids; Interleukin-6; Leishmania; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Phosphorylcholine; Tumor Necrosis Factor-alpha	2022
Meglumine antimoniate was associated with a higher cure rate than liposomal amphotericin B in the treatment of American tegumentary leishmaniasis: A retrospective cohort study from a Frontiers in cellular and infection microbiology, 2022, Volume: 12 Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Meglumine Antimoniate; Reproducibility of Results; Retrospective Studies; Treatment Outcome	2022